[go: up one dir, main page]

CO2017010091A2 - Composiciones tópicas que comprenden un corticosteroide - Google Patents

Composiciones tópicas que comprenden un corticosteroide

Info

Publication number
CO2017010091A2
CO2017010091A2 CONC2017/0010091A CO2017010091A CO2017010091A2 CO 2017010091 A2 CO2017010091 A2 CO 2017010091A2 CO 2017010091 A CO2017010091 A CO 2017010091A CO 2017010091 A2 CO2017010091 A2 CO 2017010091A2
Authority
CO
Colombia
Prior art keywords
corticosteroid
topical compositions
agent
composition
propylene glycol
Prior art date
Application number
CONC2017/0010091A
Other languages
English (en)
Inventor
Sateesh Kandavilli
Madhusudhan Bommagani
Vijendra Nalamothu
Franklin Okumu
Amalavoyal Raghav Chari
Original Assignee
Promius Pharma Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Promius Pharma Llc filed Critical Promius Pharma Llc
Publication of CO2017010091A2 publication Critical patent/CO2017010091A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composiciones tópicas que comprenden un corticosteroide y por lo menos un agente que aumenta la penetración, en donde la composición está sustancialmente libre de propilenglicol.
CONC2017/0010091A 2014-03-11 2017-10-04 Composiciones tópicas que comprenden un corticosteroide CO2017010091A2 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461951188P 2014-03-11 2014-03-11
US14/645,297 US20160184431A1 (en) 2014-03-11 2015-03-11 Topical compositions comprising a corticosteroid
PCT/US2016/022194 WO2016145407A1 (en) 2014-03-11 2016-03-11 Topical compositions comprising a corticosteroid

Publications (1)

Publication Number Publication Date
CO2017010091A2 true CO2017010091A2 (es) 2018-01-05

Family

ID=56163000

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2017/0010091A CO2017010091A2 (es) 2014-03-11 2017-10-04 Composiciones tópicas que comprenden un corticosteroide

Country Status (16)

Country Link
US (4) US20160184431A1 (es)
EP (1) EP3267978B1 (es)
JP (2) JP2018507891A (es)
KR (2) KR20170123335A (es)
CN (1) CN107872972A (es)
AU (1) AU2016228574B2 (es)
BR (1) BR112017019352B1 (es)
CA (1) CA2979051C (es)
CO (1) CO2017010091A2 (es)
EA (1) EA037380B1 (es)
ES (1) ES2861374T3 (es)
MX (1) MX2017011521A (es)
NZ (1) NZ735341A (es)
RU (1) RU2690659C2 (es)
UA (1) UA121232C2 (es)
WO (1) WO2016145407A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5833007B2 (ja) 2009-08-31 2015-12-16 ドクター・レディーズ・ラボラトリーズ・リミテッド ステロイドを含む局所製剤
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
WO2018191601A1 (en) * 2017-04-13 2018-10-18 Odan Laboratories, Ltd. Stable pharmaceutical compositions comprising desonide
WO2020181395A1 (en) 2019-03-14 2020-09-17 Crescita Therapeutics Inc. Rinse-off compositions and uses thereof for delivery of active agents
WO2021046444A1 (en) * 2019-09-06 2021-03-11 Encore Dermatology, Inc. Topical compositions comprising a corticosteroid for the treatment of psoriasis in pediatric patients
CN115103666A (zh) * 2020-02-11 2022-09-23 塔罗制药工业有限公司 包含去羟米松和他扎罗汀的组合物
CN114272203B (zh) * 2021-12-27 2023-09-26 福元药业有限公司 一种糠酸莫米松乳膏及其制备方法
WO2023172216A1 (en) * 2022-03-11 2023-09-14 Ilko Ilac Sanayi Ve Ticaret A.S. Hydrocortisone and pramoxine topical formulations having enhanced in-vitro release
WO2024005726A1 (en) * 2022-06-30 2024-01-04 Ilko Ilac Sanayi Ve Ticaret A.S. Storage stable topical composition comprising clobetasol

Family Cites Families (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892856A (en) 1974-04-10 1975-07-01 Squibb & Sons Inc Topical steroid formulation
US3934013A (en) 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition
US4053089A (en) 1975-08-01 1977-10-11 Lever Brothers Company Pump for dispensing liquids
US4343798A (en) 1981-06-23 1982-08-10 The Procter & Gamble Company Topical antimicrobial anti-inflammatory compositions
US4552872A (en) 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
WO1991008733A1 (en) 1989-12-20 1991-06-27 Schering Corporation Stable cream and lotion bases for lipophilic drug compositions
FR2656900B1 (fr) 1990-01-10 1994-01-28 Oreal Pompe manuelle a precompression pour la pulverisation d'un liquide, notamment d'un parfum.
US5068099A (en) 1990-01-16 1991-11-26 S. C. Johnson & Son, Inc. Hair spray package with low volatile organic compound emission
IT1247529B (it) 1991-04-24 1994-12-17 Poli Ind Chimica Spa Composizioni farmaceutiche in forma di schiuma per somministrazione intravaginale, cutanea e orale
WO1994013257A1 (en) 1992-12-16 1994-06-23 Creative Products Resource Associates, Ltd. Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
FR2715585B1 (fr) 1994-01-28 1996-03-08 Oreal Ensemble de distribution d'un liquide, de façon quasi-continue, comportant une pompe et utilisation d'un tel ensemble pour la pulvérisation d'une laque capillaire.
US5976555A (en) 1994-09-07 1999-11-02 Johnson & Johnson Consumer Products, Inc. Topical oil-in-water emulsions containing retinoids
ES2180599T3 (es) 1994-09-30 2003-02-16 Mika Pharma Ges Fur Die Entwic Composicion farmaceutica.
GB9504265D0 (en) 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition
ZA966579B (en) * 1995-08-04 1998-02-02 Wakamoto Pharma Co Ltd O/W emulsion composition for eye drops.
US6158617A (en) 1996-10-30 2000-12-12 The Procter & Gamble Company Concentrated reduced dosage spray pump delivery system
KR20010013377A (ko) 1997-06-04 2001-02-26 데이비드 엠 모이어 마일드한 잔류성 항균 조성물
US6075056A (en) 1997-10-03 2000-06-13 Penederm, Inc. Antifungal/steroid topical compositions
US5972920A (en) 1998-02-12 1999-10-26 Dermalogix Partners, Inc. Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders
AUPP310798A0 (en) 1998-04-22 1998-05-14 Soltec Research Pty Ltd Vehicle system for a composition comprising a piperidinopyrimidine derivative
FR2761600B1 (fr) 1998-06-19 2000-03-31 Oreal Composition moussante pour le lavage et le traitement des cheveux et/ou du cuir chevelu a base d'un principe actif, d'un tensioactif anionique, d'un tensioactif amphotere et d'un agent propenetrant
US6284234B1 (en) 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
US6670144B1 (en) 1999-02-26 2003-12-30 Cyclacel, Ltd. Compositions and methods for monitoring the phosphorylation of natural binding partners
US7393548B2 (en) 1999-03-22 2008-07-01 J.P. M.E.D. Ltd. Nano oil in glycerin emulsion
US6962691B1 (en) 1999-05-20 2005-11-08 U & I Pharmaceuticals Ltd. Topical spray compositions
US6656928B1 (en) 1999-09-02 2003-12-02 Mccadden Michael E. Composition for the topical treatment of rashes, dermatoses and lesions
US6479058B1 (en) 1999-09-02 2002-11-12 Mccadden Michael E. Composition for the topical treatment of poison ivy and other forms of contact dermatitis
US6432415B1 (en) 1999-12-17 2002-08-13 Axrix Laboratories, Inc. Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces
US7029694B2 (en) 2000-04-26 2006-04-18 Watson Laboratories, Inc. Compositions and methods for transdermal oxybutynin therapy
US6387383B1 (en) 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
US6579512B2 (en) 2001-06-15 2003-06-17 Crutchfield, Iii Charles E. Topical steroid spray
FR2830187B1 (fr) 2001-09-28 2004-10-15 Oreal Emulsion ultrafine contenant un derive haloalkynylique
KR20040066096A (ko) * 2001-10-04 2004-07-23 매크로켐 코포레이션 이부프로펜 염 유화제 및 이를 함유하는 크림 조성물
DE10154237A1 (de) 2001-11-07 2003-05-15 Steag Microparts Gmbh Zerstäuber für manuelle Betätigung
WO2003043657A1 (en) 2001-11-19 2003-05-30 Control Delivery Systems, Inc. Topical delivery of codrugs
US6765001B2 (en) 2001-12-21 2004-07-20 Medicis Pharmaceutical Corporation Compositions and methods for enhancing corticosteroid delivery
GB0217866D0 (en) 2002-08-01 2002-09-11 Steag Microparts Gmbh Low dose spray pump
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20080206161A1 (en) 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US20060018937A1 (en) 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
SI1613346T1 (sl) 2003-04-04 2013-02-28 Pah Usa 15 Llc Mikrofluidizirane emulzije olja v vodi in sestava cepiv
FR2856301B1 (fr) 2003-06-23 2007-08-03 Galderma Res & Dev Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
NZ544851A (en) 2003-06-23 2008-03-28 Macrochem Corp A vanishing cream base composition suitable for topical administration of an active agent to an animal or plant
CL2004001884A1 (es) 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
GB0403702D0 (en) * 2004-02-19 2004-03-24 Boots Co Plc Skincare compositions
US20060099173A1 (en) 2003-10-24 2006-05-11 Nancy Puglia Topical skin care composition
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
EP2468266A3 (en) 2004-04-22 2012-10-24 AcuCort AB Pharmaceutical compositions for acute glucocorticoid therapy
US20070189977A1 (en) 2004-06-07 2007-08-16 Jie Zhang Spray-on formulations and methods for dermal delivery of drugs
FR2871697B1 (fr) * 2004-06-17 2007-06-29 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile
FR2871699A1 (fr) * 2004-06-17 2005-12-23 Galderma Sa Composition de type emulsion inverse contenant du calcitrol et du 17-propionate de clobetasol, et ses utilisations en cosmetiques et en dermatologie
FR2871700B1 (fr) 2004-06-17 2006-11-17 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse
TWI397427B (zh) * 2004-08-31 2013-06-01 史迪費爾研究澳洲股份有限公司 微乳化液、次微米乳化液的方法及組成物
JP2008523021A (ja) * 2004-12-08 2008-07-03 ガルデルマ・ソシエテ・アノニム 頭皮の脂漏性皮膚炎を治療するための、プロピオン酸クロベタゾールシャンプー
US20060246098A1 (en) 2005-03-16 2006-11-02 Srinivasa Rao Stable aqueous-based emulsion formulation comprising urea and salicylic acid and method of using same
WO2006102004A2 (en) 2005-03-16 2006-09-28 Taro Pharmaceuticals U.S.A., Inc. A stable aqueous-based emulsion formulation comprising urea and salicylic acid and method of using same
FR2884419B1 (fr) 2005-04-19 2007-06-22 Galderma Sa Composition de type solution filmogene comprenant de la vitamine d ou un de ses derives et un corticosteroide, et son utilisation en dermatologie
US20060239929A1 (en) 2005-04-25 2006-10-26 Dow Gordon J Use of a clobetasol spray formulation to treat psoriasis
FR2889662B1 (fr) * 2005-08-11 2011-01-14 Galderma Res & Dev Emulsion de type huile-dans-eau pour application topique en dermatologie
WO2007025999A1 (en) * 2005-08-31 2007-03-08 Serentis Limited Use of an aureolysin inhibitor for the treatment of inflammatory skin conditions characterised by colonisation with staphylococcus aureus
FR2893845B1 (fr) 2005-11-30 2010-10-29 Galderma Sa Composition sous forme de spray comprenant un corticoide et une phase huileuse
US20070243132A1 (en) 2005-12-22 2007-10-18 Apollo Life Sciences Limited Transdermal delivery of pharmaceutical agents
US7731106B2 (en) 2006-01-04 2010-06-08 Nano Mist International, Llc Air driven delivery system for sprayable media
US20100278759A1 (en) 2006-02-08 2010-11-04 Howard Murad Topical Therapeutic Delivery System
WO2007094605A1 (en) 2006-02-14 2007-08-23 Amorepacific Corporation Topical preparation composition containing a thiourea derivative for preventing or treating pruritic or irritant skin diseases
EP1998742A2 (en) 2006-03-08 2008-12-10 Nuviance, INC. Transdermal drug delivery compositions and topical compositions for application on the skin
FR2898498B1 (fr) 2006-03-15 2008-11-28 Galderma Sa Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant
FR2898499B1 (fr) 2006-03-15 2008-11-28 Galderma Sa Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant
EP2023718A4 (en) 2006-05-11 2010-04-21 Avicena Group Inc CREATINLIGATE COMPOUNDS AND APPLICATION METHOD THEREFOR
EA200970260A1 (ru) 2006-09-08 2009-08-28 Фоамикс Лтд. Окрашенная или окрашиваемая и вспениваемая композиция и пена
GB2443162B (en) 2006-10-28 2011-02-09 Nupharm Lab Ltd Betamethasone spray
US20080206155A1 (en) 2006-11-14 2008-08-28 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
AU2007332800A1 (en) 2006-12-07 2008-06-19 Avicena Group, Inc. Creatine compositions for skin treatment
EP2173169B1 (en) 2007-06-28 2014-05-21 CyDex Pharmaceuticals, Inc. Nasal delivery of aqueous corticosteroid solutions
WO2009015456A1 (en) 2007-07-30 2009-02-05 Generex Pharmaceuticals Inc. Pharmaceutical formulation in mixed micellar form and dispenser for oral delivery of agents as a spray
JP2010535774A (ja) 2007-08-06 2010-11-25 インシス セラピューティクス インコーポレイテッド 経口カンナビノイド液体製剤および治療方法
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
MX2010002592A (es) 2007-09-10 2010-03-30 Glenmark Pharmaceuticals Ltd Composicion farmaceutica topica para la combinacion de acido fusidico y corticoesteroides.
AR068409A1 (es) 2007-09-14 2009-11-18 Drugtech Corp Composiciones farmaceuticas, transdermicas sin alcohol
US20090093547A1 (en) 2007-10-09 2009-04-09 Sciele Pharma, Inc. Compositions and Methods for Treating Premature Ejaculation
US20090130029A1 (en) 2007-11-21 2009-05-21 Foamix Ltd. Glycerol ethers vehicle and pharmaceutical compositions thereof
US20100249060A1 (en) 2009-02-23 2010-09-30 Smith Jan G Topical formulation of low level clobetasol propionate for treating disorders of the skin and mucous membranes
US20120238535A1 (en) * 2009-02-23 2012-09-20 Smith Jan G Topical formulation of low level clobetasol propionate for treating disorders of the skin and mucous membranes
DK2400951T3 (en) 2009-02-25 2018-12-03 Mayne Pharma Llc TOPICAL FOAM COMPOSITION
JP5833007B2 (ja) 2009-08-31 2015-12-16 ドクター・レディーズ・ラボラトリーズ・リミテッド ステロイドを含む局所製剤
MX359879B (es) 2009-10-02 2018-10-12 Foamix Pharmaceuticals Ltd Composiciones tópicas de tetraciclina.
EP2579851B1 (en) 2010-06-11 2022-05-04 Precision Dermatology, Inc. High oil-content emollient aerosol foam compositions
PH12013500783A1 (en) * 2010-10-21 2022-03-30 Cadila Healthcare Ltd Topical pharmaceutical compositions containing nanodroplets for the treatment of psoriasis
US8809307B2 (en) * 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
WO2012150130A1 (en) 2011-05-04 2012-11-08 Chiesi Farmaceutici S.P.A. A topical formulation comprising a corticosteroid as active ingredient
CN102526070A (zh) * 2012-01-04 2012-07-04 西北农林科技大学 一种复方联苯苄唑纳米乳喷剂及其制备方法
JP6473134B2 (ja) 2013-03-15 2019-02-20 メディシス ファーマシューティカル コーポレイション フルニソリドの局所用組成物および治療方法
US10111956B2 (en) * 2013-06-03 2018-10-30 Tolmar, Inc. Corticosteroid compositions
CN105263474A (zh) 2013-06-03 2016-01-20 托马有限公司 皮质类固醇组合物
US20150258119A1 (en) 2014-03-11 2015-09-17 Promius Pharma, LLC Topical corticosteroid compositions
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid

Also Published As

Publication number Publication date
US20160199493A1 (en) 2016-07-14
US9855334B2 (en) 2018-01-02
AU2016228574B2 (en) 2019-05-02
AU2016228574A1 (en) 2017-09-28
MX2017011521A (es) 2018-01-11
KR20170123335A (ko) 2017-11-07
JP2021008505A (ja) 2021-01-28
WO2016145407A1 (en) 2016-09-15
US20160184431A1 (en) 2016-06-30
EA037380B1 (ru) 2021-03-22
RU2017134440A3 (es) 2019-04-11
KR20200051854A (ko) 2020-05-13
RU2017134440A (ru) 2019-04-11
NZ735341A (en) 2019-05-31
US20180078643A1 (en) 2018-03-22
US20190175735A1 (en) 2019-06-13
EP3267978B1 (en) 2021-01-20
BR112017019352A2 (pt) 2018-06-05
CN107872972A (zh) 2018-04-03
ES2861374T3 (es) 2021-10-06
BR112017019352B1 (pt) 2023-12-19
EP3267978A1 (en) 2018-01-17
EA201791921A1 (ru) 2018-03-30
RU2690659C2 (ru) 2019-06-05
US11179465B2 (en) 2021-11-23
CA2979051A1 (en) 2016-09-15
UA121232C2 (uk) 2020-04-27
JP2018507891A (ja) 2018-03-22
CA2979051C (en) 2019-09-17

Similar Documents

Publication Publication Date Title
CO2017010091A2 (es) Composiciones tópicas que comprenden un corticosteroide
MX379270B (es) Composiciones que comprenden cepas bacterianas.
MX2017010872A (es) Composiciones que comprenden combinaciones de cannabinoides purificados, con al menos uno de flavonoides, terpenos o minerales.
CO2017001994A2 (es) Compuestos activos hacia bromodominios
AR100498A1 (es) Mejora en la reducción de la fricción
CO2017008219A2 (es) Composición hemostática y dispositivo hemostático (variantes)
CL2016002772A1 (es) Composiciones de insulina de rápida acción
MX373661B (es) Composiciones topicas que comprenden extractos de pichia anomala y de raiz de achicoria.
MA45857A (fr) Composés et compositions, et utilisations associées
PH12017500555A1 (en) Modified phosphpors and compositions thereof
NZ731029A (en) An antimicrobial composition
MX386298B (es) Composicion farmaceutica que comprende adalimumab.
BR112016029674A2 (pt) materiais poliméricos compostos para modificação de composições adesivas e métodos de fabricação associados
PH12015502014A1 (en) Racecadotril lipid compositions
CO2018005753A2 (es) Composición hemostática
MX2019005833A (es) Administracion transdermica de agentes grandes.
CL2018003826A1 (es) Uso de una fracción lignina como un agente anti fitopatogenico y composiciones fitopatogenicas conteniendo dicho agente.
CO2017012645A2 (es) Agente antihipertensivo que comprende s-1-propenilcisteína o una sal del mismo como ingrediente activo
EP3392261A4 (en) STEROIDAL CONNECTION, COMPOSITION THEREOF AND USE THEREOF
MX2018001512A (es) Composiciones antimicrobianas que comprenden mupirocina y neomicina.
BR112017011685A2 (pt) composições compreendendo 15-hepe e métodos de tratamento ou prevenção da fibrose usando as mesmas
MA45795A (fr) Composés et compositions, et utilisations associées
ITUA20163227A1 (it) Composizioni cosmetiche contenenti diglicerolo tetrapelargonato.
MX390214B (es) Composicion que comprende agente beneficioso y solvente aprotico.
PH12017502148A1 (en) Pharmaceutical compositions and use thereof